AMENDMENT TO TERRITORY LICENSE AND SUPPLY AGREEMENTSTerritory License and Supply Agreements • August 4th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment to the Territory License Agreement and the Supply Agreement previously executed by the parties and referenced below (the “Amendment”) effective as of April 1, 2010 (the “Amendment Effective Date”), by and between Molecular Insight Pharmaceuticals, Inc. (“MIP”), having an office at 160 Second Street, Cambridge, MA 02142 USA, and BioMedica Life Sciences S.A., (“BioMedica”) having an office at 4 Papanikoli Street, 15232 Halandri, Athens, Greece, each referred to herein individually as a “Party” and collectively as the “Parties.”
